HEIM, J.; VASQUEZ, J. G.; SCHENKEL, B.; BHATIA, N. Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s135, 2023. DOI: 10.25251/skin.7.supp.135. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2006. Acesso em: 4 jul. 2024.